• Report Description
  • Table Of Content
  • Request Methodology

Industry Insights

The antiviral therapeutics market is anticipated to flourish at a CAGR of 5.8% over the forecast period i.e. 2019-2024. Further, the market for antiviral therapeutics was valued at USD XXX.X million in 2018.

Growth Drivers – Antiviral Therapeutics Market

Increasing Prevalence of HIV Infection

Rising prevalence of HIV and hepatitis C infections across the globe is resulting in increased demand for antiviral therapeutics. According to the World Health Organization, in 2018, 37.9 Million were living with HIV in the world. Further, according to another WHO report, an estimated 71 million people are suffering from chronic hepatitis C virus infection. Antiviral drugs can treat more than 95% of hepatitis C patients. However, lack of access to diagnosis and treatment is resulting in low treatment ratio. Further, various healthcare organizations and governments are working on reducing the death rate and providing healthcare access to people. This factor is anticipated to strengthen the growth of global antiviral therapeutics market during the forecast period.

Launch of New Drugs

Various leading pharmaceutical companies are focusing on the introduction of new and effective drugs in the market. Furthermore, upcoming patent expiry of few drugs is anticipated to increase the flow of generic drugs in the market. These factors are envisioned to bolster the growth of antiviral therapeutics market.

Barriers – Antiviral Therapeutics Market

High Cost of Therapeutic Treatment

Factors such as high cost of antiviral drug treatment are hindering the growth of global antiviral therapeutics. Moreover, the growing use of natural products and the high cost of developing drugs is also acting as a restraint for global antiviral therapeutics market.

Segmentation Analysis

The antiviral therapeutics market by type is segmented into generic and branded. The market for generic captured the highest percentage in 2018. Moreover, it is anticipated to continue its dominance during the forecast period. In drug type segment, HIV antiviral drugs segment is anticipated to capture the largest percentage share of the market.

Further, global antiviral therapeutics market is also segmented by distribution channel into hospital pharmacy, retail pharmacy store, and online pharmacy. Retail pharmacy segment captured high market share during the forecast period. However, online pharmacy is anticipated to witness the highest growth in the upcoming years. Factors such as increasing penetration of internet and rising online pharmacies across the world are anticipated to bolster the growth of antiviral drugs online retailing market.

Geographical Analysis

Geographically, the report offers an analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In the antiviral therapeutics market, North America accounted for the largest percentage of the market in global antiviral therapeutics market. Increasing prevalence of HIV infections and hepatitis C in North America is anticipated to further drive the growth of North America antiviral therapeutics market. According to U.S. Department of Health & Human Services, about 1.1 million people were living with HIV in 2017. Moreover, around 38,700 new patients were diagnosed in 2016. This factor is anticipated to pave the way for the growth of North America antiviral therapeutics market. Asia Pacific antiviral therapeutics market is anticipated to witness robust growth during the forecast period. Increasing base of the target population and the rising presence of leading pharmaceutical companies is anticipated to impel the growth of Asia Pacific antiviral therapeutics market.

Competitive Landscape
The report profiles various major market players such as
- AbbVie Inc.
- Bristol-Meyrs Squibb Company
- Cipla Inc.
- F. Hoffmann-La Roche Ltd
- Gilead Sciences Inc
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Pfizer Inc.
- Sanofi
- Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides a company’s positioning and market share in antiviral therapeutics market.

Timeline Considered for Analysis:
- 2014 to 2017: Historical Review
- 2018: Base Year
- 2019 to 2024: Forecast Period

Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis

Market Segmentation Analysis:
Industry report analyzes the global antiviral therapeutics market by the following segments:
- Type
- Drug Type
- Distribution Channel

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Antiviral Therapeutics Industry Report
• What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
• Which region would have a high demand for a product in the upcoming years?
• What are the factors driving the growth of the market?
• Which sub-market will make the most significant contribution to the market?
• What are the market opportunities for existing and entry-level players?
• What are various long-term and short-term strategies adopted by the market players?

1. Preface
1.1. Research Methodology
1.2. Geographic Scope
1.3. Years Considered

2. Executive Summary

3. Market Overview
3.1. Antiviral Therapeutics Overview
3.2. Market Definition & Key Market Segments
3.3. Industry Development
3.4. Global Market Maturity
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
3.5. Porter’s Five Force Analysis
3.6. Industry Value Chain Analysis
3.7. Macro-Economic Trends

4. Competitive Landscape
4.1. Global Antiviral Therapeutics Market 2018
4.2. Global Antiviral Therapeutics Market Value Share, By Company 2018
4.3. Global Antiviral Therapeutics Market Volume Share, By Company 2018

5. Growth Drivers & Barriers in Global Antiviral Therapeutics Market
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Rest of World

6. Trends in Global Antiviral Therapeutics Market
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Rest of World

7. Global Antiviral Therapeutics Market
7.1. Introduction
7.2. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

8. Global Antiviral Therapeutics Market Segmentation Analysis, By Type
8.1. Introduction
8.2. Strategic Insights
8.2.1. BPS Analysis, By Type
8.2.2. Market Attractiveness, By Type
8.3. Generic
8.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
8.4. Branded
8.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9. Global Antiviral Therapeutics Market Segmentation Analysis, By Drug Type
9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Drug Type
9.2.2. Market Attractiveness, By Drug Type
9.3. Herpes Antiviral Drugs
9.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.4. Hepatitis Antiviral Drugs
9.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.5. HIV Antiviral Drugs
9.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.6. Influenza Antiviral Drugs
9.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.7. Others Antiviral Drugs
9.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

10. Global Antiviral Therapeutics Market Segmentation Analysis, By Mechanism of Action
10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Mechanism of Action
10.2.2. Market Attractiveness, By Mechanism of Action
10.3. Nucleotide Polymerase Inhibitor
10.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4. Reverse Transcriptase Inhibitor
10.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5. Protease Inhibitor
10.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

11. Global Antiviral Therapeutics Market Segmentation Analysis, By Distribution Channel
11.1. Introduction
11.2. Strategic Insights
11.2.1. BPS Analysis, By Distribution Channel
11.2.2. Market Attractiveness, By Distribution Channel
11.3. Hospital Pharmacy Store
11.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
11.4. Retail Pharmacy Store
11.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
11.5. Online Pharmacy
11.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12. Geographical Analysis
12.1. Introduction
12.2. North America Antiviral Therapeutics Market
12.2.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.2. By Type
12.2.2.1. Introduction
12.2.2.2. Strategic Insights
12.2.2.2.1. BPS Analysis, By Type
12.2.2.2.2. Market Attractiveness, By Type
12.2.2.3. Generic
12.2.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.2.4. Branded
12.2.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3. By Drug Type
12.2.3.1. Introduction
12.2.3.2. Strategic Insights
12.2.3.2.1. BPS Analysis, By Drug Type
12.2.3.2.2. Market Attractiveness, By Drug Type
12.2.3.3. Herpes Antiviral Drugs
12.2.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.4. Hepatitis Antiviral Drugs
12.2.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.5. HIV Antiviral Drugs
12.2.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.6. Influenza Antiviral Drugs
12.2.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.7. Others Antiviral Drugs
12.2.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.4. By Mechanism of Action
12.2.4.1. Introduction
12.2.4.2. Strategic Insights
12.2.4.2.1. BPS Analysis, By Mechanism of Action
12.2.4.2.2. Market Attractiveness, By Mechanism of Action
12.2.4.3. Nucleotide Polymerase Inhibitor
12.2.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.4.4. Reverse Transcriptase Inhibitor
12.2.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.4.5. Protease Inhibitor
12.2.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.5. By Distribution Channel
12.2.5.1. Introduction
12.2.5.2. Strategic Insights
12.2.5.2.1. BPS Analysis, By Distribution Channel
12.2.5.2.2. Market Attractiveness, By Distribution Channel
12.2.5.3. Hospital Pharmacy Store
12.2.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.5.4. Retail Pharmacy Store
12.2.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.5.5. Online Pharmacy
12.2.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.6. By Country
12.2.6.1. Introduction
12.2.6.2. Strategic Insights
12.2.6.2.1. BPS Analysis, By Country
12.2.6.2.2. Market Attractiveness, By Country
12.2.6.3. U.S. Antiviral Therapeutics Market
12.2.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.6.4. Canada Antiviral Therapeutics Market
12.2.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3. Europe Antiviral Therapeutics Market
12.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.2. By Type
12.3.2.1. Introduction
12.3.2.2. Strategic Insights
12.3.2.2.1. BPS Analysis, By Type
12.3.2.2.2. Market Attractiveness, By Type
12.3.2.3. Generic
12.3.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.2.4. Branded
12.3.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3. By Drug Type
12.3.3.1. Introduction
12.3.3.2. Strategic Insights
12.3.3.2.1. BPS Analysis, By Drug Type
12.3.3.2.2. Market Attractiveness, By Drug Type
12.3.3.3. Herpes Antiviral Drugs
12.3.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.4. Hepatitis Antiviral Drugs
12.3.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.5. HIV Antiviral Drugs
12.3.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.6. Influenza Antiviral Drugs
12.3.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.7. Others Antiviral Drugs
12.3.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.4. By Mechanism of Action
12.3.4.1. Introduction
12.3.4.2. Strategic Insights
12.3.4.2.1. BPS Analysis, By Mechanism of Action
12.3.4.2.2. Market Attractiveness, By Mechanism of Action
12.3.4.3. Nucleotide Polymerase Inhibitor
12.3.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.4.4. Reverse Transcriptase Inhibitor
12.3.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.4.5. Protease Inhibitor
12.3.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.5. By Distribution Channel
12.3.5.1. Introduction
12.3.5.2. Strategic Insights
12.3.5.2.1. BPS Analysis, By Distribution Channel
12.3.5.2.2. Market Attractiveness, By Distribution Channel
12.3.5.3. Hospital Pharmacy Store
12.3.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.5.4. Retail Pharmacy Store
12.3.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.5.5. Online Pharmacy
12.3.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6. By Country
12.3.6.1. Introduction
12.3.6.2. Strategic Insights
12.3.6.2.1. BPS Analysis, By Country
12.3.6.2.2. Market Attractiveness, By Country
12.3.6.3. Germany Antiviral Therapeutics Market
12.3.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6.4. United Kingdom Antiviral Therapeutics Market
12.3.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6.5. France Antiviral Therapeutics Market
12.3.6.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6.6. Italy Antiviral Therapeutics Market
12.3.6.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6.7. Spain Antiviral Therapeutics Market
12.3.6.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6.8. Russia Antiviral Therapeutics Market
12.3.6.8.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.6.9. Rest of Europe Antiviral Therapeutics Market
12.3.6.9.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.4. Asia Pacific Antiviral Therapeutics Market
12.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.2. By Type
12.4.2.1. Introduction
12.4.2.2. Strategic Insights
12.4.2.2.1. BPS Analysis, By Type
12.4.2.2.2. Market Attractiveness, By Type
12.4.2.3. Generic
12.4.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.2.4. Branded
12.4.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.3. By Drug Type
12.4.3.1. Introduction
12.4.3.2. Strategic Insights
12.4.3.2.1. BPS Analysis, By Drug Type
12.4.3.2.2. Market Attractiveness, By Drug Type
12.4.3.3. Herpes Antiviral Drugs
12.4.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.3.4. Hepatitis Antiviral Drugs
12.4.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.3.5. HIV Antiviral Drugs
12.4.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.3.6. Influenza Antiviral Drugs
12.4.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.3.7. Others Antiviral Drugs
12.4.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.4. By Mechanism of Action
12.4.4.1. Introduction
12.4.4.2. Strategic Insights
12.4.4.2.1. BPS Analysis, By Mechanism of Action
12.4.4.2.2. Market Attractiveness, By Mechanism of Action
12.4.4.3. Nucleotide Polymerase Inhibitor
12.4.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.4.4. Reverse Transcriptase Inhibitor
12.4.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.4.5. Protease Inhibitor
12.4.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.5. By Distribution Channel
12.4.5.1. Introduction
12.4.5.2. Strategic Insights
12.4.5.2.1. BPS Analysis, By Distribution Channel
12.4.5.2.2. Market Attractiveness, By Distribution Channel
12.4.5.3. Hospital Pharmacy Store
12.4.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.5.4. Retail Pharmacy Store
12.4.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.5.5. Online Pharmacy
12.4.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6. By Country
12.4.6.1. Introduction
12.4.6.2. Strategic Insights
12.4.6.2.1. BPS Analysis, By Country
12.4.6.2.2. Market Attractiveness, By Country
12.4.6.3. China Antiviral Therapeutics Market
12.4.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.4. India Antiviral Therapeutics Market
12.4.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.5. Japan Antiviral Therapeutics Market
12.4.6.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.6. South Korea Antiviral Therapeutics Market
12.4.6.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.7. Indonesia Antiviral Therapeutics Market
12.4.6.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.8. Taiwan Antiviral Therapeutics Market
12.4.6.8.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.9. Australia Antiviral Therapeutics Market
12.4.6.9.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.10. New Zealand Antiviral Therapeutics Market
12.4.6.10.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.4.6.11. Rest of Asia Pacific Antiviral Therapeutics Market
12.4.6.11.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.5. Latin America Antiviral Therapeutics Market
12.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.2. By Type
12.5.2.1. Introduction
12.5.2.2. Strategic Insights
12.5.2.2.1. BPS Analysis, By Type
12.5.2.2.2. Market Attractiveness, By Type
12.5.2.3. Generic
12.5.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.2.4. Branded
12.5.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.3. By Drug Type
12.5.3.1. Introduction
12.5.3.2. Strategic Insights
12.5.3.2.1. BPS Analysis, By Drug Type
12.5.3.2.2. Market Attractiveness, By Drug Type
12.5.3.3. Herpes Antiviral Drugs
12.5.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.3.4. Hepatitis Antiviral Drugs
12.5.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.3.5. HIV Antiviral Drugs
12.5.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.3.6. Influenza Antiviral Drugs
12.5.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.3.7. Others Antiviral Drugs
12.5.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.4. By Mechanism of Action
12.5.4.1. Introduction
12.5.4.2. Strategic Insights
12.5.4.2.1. BPS Analysis, By Mechanism of Action
12.5.4.2.2. Market Attractiveness, By Mechanism of Action
12.5.4.3. Nucleotide Polymerase Inhibitor
12.5.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.4.4. Reverse Transcriptase Inhibitor
12.5.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.4.5. Protease Inhibitor
12.5.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.5. By Distribution Channel
12.5.5.1. Introduction
12.5.5.2. Strategic Insights
12.5.5.2.1. BPS Analysis, By Distribution Channel
12.5.5.2.2. Market Attractiveness, By Distribution Channel
12.5.5.3. Hospital Pharmacy Store
12.5.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.5.4. Retail Pharmacy Store
12.5.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.5.5. Online Pharmacy
12.5.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.6. By Country
12.5.6.1. Introduction
12.5.6.2. Strategic Insights
12.5.6.2.1. BPS Analysis, By Country
12.5.6.2.2. Market Attractiveness, By Country
12.5.6.3. Brazil Antiviral Therapeutics Market
12.5.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.6.4. Mexico Antiviral Therapeutics Market
12.5.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.5.6.5. Rest of Latin America Antiviral Therapeutics Market
12.5.6.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.6. Middle East & Africa Antiviral Therapeutics Market
12.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.2. By Type
12.6.2.1. Introduction
12.6.2.2. Strategic Insights
12.6.2.2.1. BPS Analysis, By Type
12.6.2.2.2. Market Attractiveness, By Type
12.6.2.3. Generic
12.6.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.2.4. Branded
12.6.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.3. By Drug Type
12.6.3.1. Introduction
12.6.3.2. Strategic Insights
12.6.3.2.1. BPS Analysis, By Drug Type
12.6.3.2.2. Market Attractiveness, By Drug Type
12.6.3.3. Herpes Antiviral Drugs
12.6.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.3.4. Hepatitis Antiviral Drugs
12.6.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.3.5. HIV Antiviral Drugs
12.6.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.3.6. Influenza Antiviral Drugs
12.6.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.3.7. Others Antiviral Drugs
12.6.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.4. By Mechanism of Action
12.6.4.1. Introduction
12.6.4.2. Strategic Insights
12.6.4.2.1. BPS Analysis, By Mechanism of Action
12.6.4.2.2. Market Attractiveness, By Mechanism of Action
12.6.4.3. Nucleotide Polymerase Inhibitor
12.6.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.4.4. Reverse Transcriptase Inhibitor
12.6.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.4.5. Protease Inhibitor
12.6.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.5. By Distribution Channel
12.6.5.1. Introduction
12.6.5.2. Strategic Insights
12.6.5.2.1. BPS Analysis, By Distribution Channel
12.6.5.2.2. Market Attractiveness, By Distribution Channel
12.6.5.3. Hospital Pharmacy Store
12.6.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.5.4. Retail Pharmacy Store
12.6.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.5.5. Online Pharmacy
12.6.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.6. By Geography
12.6.6.1. Introduction
12.6.6.2. Strategic Insights
12.6.6.2.1. BPS Analysis, By Geography
12.6.6.2.2. Market Attractiveness, By Geography
12.6.6.3. GCC Antiviral Therapeutics Market
12.6.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.6.4. North Africa Antiviral Therapeutics Market
12.6.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.6.5. South Africa Antiviral Therapeutics Market
12.6.6.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.6.6.6. Rest of Middle East & Africa Antiviral Therapeutics Market
12.6.6.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

13. Competitive Landscape
13.1. Market Share of Key Players in Antiviral Therapeutics Market
13.2. Antiviral Therapeutics Company Analysis
13.2.1. AbbVie Inc.
13.2.1.1. Company Overview
13.2.1.2. Product Offered
13.2.1.3. Business Strategy
13.2.1.4. Financials
13.2.1.5. SWOT Analysis
13.2.1.6. Market Share Analysis
13.2.1.7. Key Achievements & Developments
13.2.2. Bristol-Meyrs Squibb Company
13.2.3. Cipla Inc.
13.2.4. F. Hoffmann-La Roche Ltd
13.2.5. Gilead Sciences Inc
13.2.6. GlaxoSmithKline Plc
13.2.7. Johnson & Johnson
13.2.8. Merck & Co. Inc.
13.2.9. Pfizer Inc.
13.2.10. Sanofi
13.2.11. Other Major & Niche Players

14. Disclaimer

Select License Type
  • Single User License $3375 USD
  • Multi-User License $4185 USD
  • Corporate User License $4995 USD

Request For Customization



Request Customization

Check Discount



Request Discount

Corporate Clients

More than 200 Clients